Davidt Doherty News Today

Benchmark reissued their buy rating on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Citigroup decreased their price target on Surgery Partners from […]

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a research note issued on Wednesday, Benzinga reports. They currently have a $43.00 price objective on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 63.13% from the company’s previous close. Several […]

Clough Capital Partners L P lessened its holdings in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 31.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 137,903 shares of the company’s stock after selling 63,900 shares during the period. Clough Capital Partners L P owned 0.11% […]

Landscape Capital Management L.L.C. purchased a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 9,649 shares of the company’s stock, valued at approximately $269,000. Several other institutional investors have also […]

Surgery Partners (NASDAQ:SGRY – Get Rating) had its price target boosted by Citigroup from $40.00 to $47.00 in a research report sent to investors on Tuesday, The Fly reports. Several other equities analysts have also recently issued reports on SGRY. JPMorgan Chase & Co. decreased their target price on shares of Surgery Partners from $45.00 […]

Surgery Partners (NASDAQ:SGRY – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Tuesday. SGRY has been the subject of a number of other research reports. Barclays decreased their price target on shares of Surgery Partners from $69.00 to $56.00 […]

Surgery Partners (NASDAQ:SGRY – Get Rating) is set to issue its quarterly earnings data after the market closes on Monday, May 1st. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Surgery Partners has set its FY 2023 guidance at EPS.Individual interested in listening to the company’s earnings conference call […]

BRENTWOOD, Tenn., March 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the

Wall Street brokerages expect Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) to announce earnings of ($0.03) per share for the current quarter, Zacks reports. Five analysts have made estimates for Surgery Partners’ earnings. The highest EPS estimate is ($0.01) and the lowest is ($0.07). The business is scheduled to report its next quarterly earnings report […]

Surgery Partners (NASDAQ: SGRY) recently received a number of ratings updates from brokerages and research firms: 5/12/2022 – Surgery Partners was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 5/10/2022 – Surgery Partners was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According […]